MedPath

Megestrol Acetate

Megestrol Acetate Tablet USP

Approved
Approval ID

1ead6d47-c975-4c1b-a756-7999d8bb8ef8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 15, 2023

Manufacturers
FDA

Golden State Medical Supply, Inc.

DUNS: 603184490

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60429-433
Application NumberANDA072423
Product Classification
M
Marketing Category
C73584
G
Generic Name
Megestrol Acetate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 15, 2023
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 40 mg in 1 1
Code: TJ2M0FR8ES
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Megestrol Acetate - FDA Drug Approval Details